Venn Life Sciences (LON:VENN) Shares Pass Below Two Hundred Day Moving Average of $6.85

Shares of Venn Life Sciences Holdings PLC (LON:VENN) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 6.85 ($0.09) and traded as low as GBX 6.70 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares changing hands.

Venn Life Sciences Trading Up 7.0 %

The company has a quick ratio of 1.48, a current ratio of 2.30 and a debt-to-equity ratio of 35.83. The firm has a market capitalization of £4.89 million and a price-to-earnings ratio of -2.14. The firm’s 50 day moving average is GBX 6.85 and its 200 day moving average is GBX 6.85.

About Venn Life Sciences

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.